Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Baguley

Showing results (1-10 of 273) with videos related to

Pageof 28
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
Small-molecule cytokine inducers causing tumor necrosisB C Baguley
Biophysical Chemistry|April 1, 1990
The possible role of electron-transfer complexes in the antitumour action of amsacrine analoguesB C Baguley
The New Zealand Medical Journal|November 27, 1991
Topoisomerases and cancer treatmentB C Baguley
The New Zealand Medical Journal|October 26, 1988
The potential of molecular and cellular biologyB C Baguley
Molecular and Cellular Biochemistry|April 2, 1982
Nonintercalative DNA-binding antitumour compoundsB C Baguley
Journal of the National Cancer Institute|July 3, 1991
Cell cycling, cdc2, and cancerB C Baguley
Anti-Cancer Drug Design|February 1, 1991
DNA intercalating anti-tumour agentsB C Baguley
Cellular Immunology|August 1, 1976
The immunological status of mice during the generation of cyclophosphamide-induced toleranceJ Marbrook, B C Baguley
European Journal of Cancer|June 1, 1981
Antitumour activity of substituted 9-anilinoacridines--comparison of in vivo and in vitro testing systemsB C Baguley, R Nash
International Archives of Allergy and Applied Immunology|January 1, 1971
The recovery of immune responsiveness after treatment with cyclophosphamideJ Marbrook, B C Baguley
Pageof 28

Showing results (1-10 of 273) with videos related to

Sort By:
Pageof 28
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2002
Small-molecule cytokine inducers causing tumor necrosisB C Baguley
Biophysical Chemistry|April 1, 1990
The possible role of electron-transfer complexes in the antitumour action of amsacrine analoguesB C Baguley
The New Zealand Medical Journal|November 27, 1991
Topoisomerases and cancer treatmentB C Baguley
The New Zealand Medical Journal|October 26, 1988
The potential of molecular and cellular biologyB C Baguley
Molecular and Cellular Biochemistry|April 2, 1982
Nonintercalative DNA-binding antitumour compoundsB C Baguley
Journal of the National Cancer Institute|July 3, 1991
Cell cycling, cdc2, and cancerB C Baguley
Anti-Cancer Drug Design|February 1, 1991
DNA intercalating anti-tumour agentsB C Baguley
Cellular Immunology|August 1, 1976
The immunological status of mice during the generation of cyclophosphamide-induced toleranceJ Marbrook, B C Baguley
European Journal of Cancer|June 1, 1981
Antitumour activity of substituted 9-anilinoacridines--comparison of in vivo and in vitro testing systemsB C Baguley, R Nash
International Archives of Allergy and Applied Immunology|January 1, 1971
The recovery of immune responsiveness after treatment with cyclophosphamideJ Marbrook, B C Baguley
Pageof 28